Home  |  About us  |  Editorial board  |  Current issue  |  Archives  |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |  Reader Login
  Users Online: 113Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2013| October-December  | Volume 4 | Issue 4  
    Online since October 22, 2013

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
ORIGINAL ARTICLES
An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study
Akram Ahmad, Isha Patel, Rajesh Balkrishnan, GP Mohanta, PK Manna
October-December 2013, 4(4):204-210
DOI:10.4103/2229-3485.120168  PMID:24312887
  7 2,832 571
PHARMACOVIGILANCE
Causality assessment: A brief insight into practices in pharmaceutical industry
R Purushotham Naidu
October-December 2013, 4(4):233-236
DOI:10.4103/2229-3485.120173  PMID:24312892
  5 2,014 405
ORIGINAL ARTICLES
Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients
Dishank Patel, Mira Desai, AN Shah, RK Dikshit
October-December 2013, 4(4):215-220
DOI:10.4103/2229-3485.120170  PMID:24312889
  3 1,285 239
OPINION
Causality assessment: A casualty of compensation?
Anuradha Kulkarni, Arun Bhatt
October-December 2013, 4(4):196-198
DOI:10.4103/2229-3485.120166  PMID:24312885
  1 1,211 292
CONFERENCE PROCEEDING
Practical solutions to challenges in research ethics proceedings of Bangalore conference
Marjorie A Speers, Laxminarayana K Bairy
October-December 2013, 4(4):227-232
DOI:10.4103/2229-3485.120172  PMID:24312891
  - 883 133
EDITORIAL
Taking the 'Risk' out of risk-based monitoring
Ashwaria Gupta
October-December 2013, 4(4):193-195
DOI:10.4103/2229-3485.120165  PMID:24312884
  - 1,055 4,440
LETTERS TO EDITOR
Transparency in recruiting patients for clinical trials
Veena Joshi
October-December 2013, 4(4):239-240
DOI:10.4103/2229-3485.120175  PMID:24312894
  - 690 161
Indian Medical Research: Encouraging trends
Sanjay Kalra, Bharti Kalra, Vibha Pathak
October-December 2013, 4(4):240-241
DOI:10.4103/2229-3485.120176  PMID:24312895
  - 721 154
ORIGINAL ARTICLES
A data-driven approach to quality risk management
Demissie Alemayehu, Jose Alvir, Marcia Levenstein, David Nickerson
October-December 2013, 4(4):221-226
DOI:10.4103/2229-3485.120171  PMID:24312890
  - 954 216
Feasibility study of clinical trial for breast cancer and lung cancer at Indian sites
Varun M Mehta, Arun D Bhatt
October-December 2013, 4(4):211-214
DOI:10.4103/2229-3485.120169  PMID:24312888
  - 1,026 160
REGULATORY
Injury and death in clinical trials and compensation: Rule 122 DAB
Ravindra B Ghooi
October-December 2013, 4(4):199-203
DOI:10.4103/2229-3485.120167  PMID:24312886
  - 1,482 337
REGULATORY UPDATES
Indian regulatory update 2013
Kedar Suvarnapathaki
October-December 2013, 4(4):237-238
DOI:10.4103/2229-3485.120174  PMID:24312893
  - 684 274
  Feedback 
  Subscribe